Artwork

İçerik Epstein Becker & Green, P.C., Epstein Becker, and P.C. tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Epstein Becker & Green, P.C., Epstein Becker, and P.C. veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !

Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs

22:01
 
Paylaş
 

Manage episode 348573783 series 2965576
İçerik Epstein Becker & Green, P.C., Epstein Becker, and P.C. tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Epstein Becker & Green, P.C., Epstein Becker, and P.C. veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

In the aftermath of the Dobbs v. Jackson Women's Health Organization decision, important questions have emerged about the current legal and regulatory landscape surrounding patient access to drugs that have historically been used to induce abortions. How can health care providers and pharmacies navigate these new restrictions? On this episode, Epstein Becker Green attorneys Delia Deschaine, Spreeha Choudhury, and Jessika Tuazon discuss the impact of the Dobbs decision on pharmacies and pharmacists, including patient access to certain reproductive health or abortion-inducing medications, dispensing of drugs, and scope of professional practice requirements.

Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc53.

Subscribe for email notifications: https://www.ebglaw.com/subscribe.

Visit: http://diagnosinghealthcare.com.

The EMPLOYMENT LAW THIS WEEK® and DIAGNOSING HEALTH CARE podcasts are presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

  continue reading

76 bölüm

Artwork
iconPaylaş
 
Manage episode 348573783 series 2965576
İçerik Epstein Becker & Green, P.C., Epstein Becker, and P.C. tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Epstein Becker & Green, P.C., Epstein Becker, and P.C. veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

In the aftermath of the Dobbs v. Jackson Women's Health Organization decision, important questions have emerged about the current legal and regulatory landscape surrounding patient access to drugs that have historically been used to induce abortions. How can health care providers and pharmacies navigate these new restrictions? On this episode, Epstein Becker Green attorneys Delia Deschaine, Spreeha Choudhury, and Jessika Tuazon discuss the impact of the Dobbs decision on pharmacies and pharmacists, including patient access to certain reproductive health or abortion-inducing medications, dispensing of drugs, and scope of professional practice requirements.

Visit our site for related resources and email contact information: https://www.ebglaw.com/dhc53.

Subscribe for email notifications: https://www.ebglaw.com/subscribe.

Visit: http://diagnosinghealthcare.com.

The EMPLOYMENT LAW THIS WEEK® and DIAGNOSING HEALTH CARE podcasts are presented by Epstein Becker & Green, P.C. All rights are reserved. This audio recording includes information about legal issues and legal developments. Such materials are for informational purposes only and may not reflect the most current legal developments. These informational materials are not intended, and should not be taken, as legal advice on any particular set of facts or circumstances, and these materials are not a substitute for the advice of competent counsel. The content reflects the personal views and opinions of the participants. No attorney-client relationship has been created by this audio recording. This audio recording may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules. The determination of the need for legal services and the choice of a lawyer are extremely important decisions and should not be based solely upon advertisements or self-proclaimed expertise. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers.

  continue reading

76 bölüm

Tüm bölümler

×
 
Loading …

Player FM'e Hoş Geldiniz!

Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.

 

Hızlı referans rehberi